DIGITEK (digoxin tablets, USP) – On April 25, 2008, the FDA released a notice posted by the manufacturer of Digitek that the product was being recalled due to defects in dosage.  The defect in dosage was the result of a manufacturing defect that led patients to receive double the dose of the active ingredient.  Digitek is manufactured by Actavis Towtowa and sold by Mylan Pharmaceuticals (NYSE: MYL) under a "Bertek" label and by UDL Laboratories under a "UDL" label.  The generic form, digoxin, is sold by several different companies.

It was reported that the tablets contained double their listed dosage causing renal failure, nausea, vomiting, dizziness, low blood pressure, cardiac instability, heart palpitations, and bradycardia (a slower than normal heartbeat).

The negligence exhibited by these pharmaceutical companies has led thousands of innocent people to experience these serious and often fatal reactions.  We intend to hold them accountable for their reckless behavior.

Unsafe drug cases are complex and costly to litigate. Experienced representation is essential, and that is exactly what we help provide. If you believe you or a loved one suffered a serious complication as a result of taking Digitek tablets, please fill out the form below for a free evaluation.

Keywords: Digitek Lawsuit | Digitek Attorney | Digitek Lawyer | Digitek Attorneys | Digitek Lawyers